Opioid and Pain Treatment in Indigenous Communities (OPTIC) Trial
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of New Mexico
About this trial
The present study seeks to examine the implementation process of culturally tailoring screening and brief intervention for both chronic pain and opioid misuse/opioid use disorder in three American Indian and Alaska Native (AI/AN) serving clinics. The investigators also will assess staff perspectives on this implementation as well as a survey to understand clients at these sites who have chronic pain and opioid misuse/opioid use disorder.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Willing and able to provide informed consent
have English comprehension and proficiency
receiving services at one of our participating study sites
report current chronic pain and/or opioid misuse/opioid use disorder
Disqualifiers
if they have a psychiatric, cognitive, or medical condition that interferes with the consenting process
Trial design
Design model
Parallel
Treatments tested in this trial
Implementation Strategies
BehavioralCulturally centering screening and brief intervention for chronic pain and opioid misuse/opioid use disorder among American Indian/Alaska Native clients
Treatment groups
225 Participants
are divided into 4 treatment groupsGroup A: Pre-InterventionNo intervention 0 interventions
Group B: InterventionNo intervention 0 interventions
Group C: ImplementationActive comparator 1 intervention
Group D: SustainmentNo intervention 0 interventions
Trial outcomes
Primary outcomes
1
Number of clients screened for chronic pain and opioid misuse/opioid use disorder
Derived from electronic medical records
Time frame
6 months (or duration of implementation phase)2
Number of clients screened for chronic pain and opioid misuse/opioid use disorder
Derived from electronic medical records
Time frame
6 months (or duration of sustainment phase)Sponsors and contacts
Click on the lead sponsor to view all of their trials.
University of New Mexico
Lead sponsor
National Institute on Drug Abuse (NIDA)
Collaborator
Source ClinicalTrials.gov